Skip to content
Search

Latest Stories

Adani in £8.58 billion deal for Holcim India cement business

Adani in £8.58 billion deal for Holcim India cement business

INDIAN billionaire Gautam Adani struck a $10.5 billion (£8.58 bn) deal to buy Swiss cement giant Holcim's local business, the companies said, betting on a construction boom predicted in coming decades.

In his biggest acquisition to date, the deal will give coal-to-ports magnate Adani - who vies with fellow Indian Mukesh Ambani for the title of Asia's richest person - a controlling stake in India's second-largest cement manufacturer.

Once approved by regulators and shareholders, the Adani Group will acquire Holcim's stakes in local producers Ambuja Cements and ACC.


The acquisitions will make Adani the country's second-biggest cement maker with a capacity of 70 million tons per year.

"Our move into the cement business is yet another validation of our belief in our nation's growth story," Adani, 59, said in a statement late Sunday (15).

"Not only is India expected to remain one of the world's largest demand-driven economies for several decades, India also continues to be the world's second largest cement market," he added.

The deal marks Holcim's exit from the Indian market after 17 years and is a part of a global restructuring strategy after the Swiss cement giant's 2015 merger with France's Lafarge.

India, already home to 1.4 billion people, is projected by the United Nations to become the planet's most populous nation by the middle of the decade.

The International Energy Agency said in a report last year that an estimated 270 million people will be added to India's urban population by 2040 - the equivalent of adding a new city the size of Los Angeles each year.

This will also likely increase emissions in the world's third-biggest polluter, since the manufacture of cement produces carbon dioxide.

Shares in Ambuja Cements were up 3.80 per cent, while shares in ACC Ltd rose six per cent in Mumbai following the announcement.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less
Grant Thornton's Anuj Chande urges UK firms to tap booming India

Anuj Chande

Grant Thornton's Anuj Chande urges UK firms to tap booming India

INDIAN companies are well placed to support the UK’s economic growth, Eastern Eye has been told by Anuj Chande, partner and head of the South Asia Business Group at Grant Thornton.

He was speaking after the publication of Grant Thornton’s India Meets Britain Tracker 2025: The latest trends in Indian investment in the UK, which was released last week. While companies in India need little encouragement to enter the UK market, the reverse is not true.

Keep ReadingShow less